Literature DB >> 14686565

Efficacy of radiofrequency volumetric tissue reduction of the soft palate in the treatment of snoring.

T J Fang1, H Y Li, C W Shue, L A Lee, P C Wang.   

Abstract

Traditional surgery for snoring often leads to intolerable postoperative pain. A new surgical treatment, radiofrequency volumetric tissue reduction (RVTR) of the soft palate, was carried out and its effect and safety in the management of snoring were evaluated. Thirty-two patients received a single treatment of RVTR with a mean follow-up period of 4.5 months. All patients were assessed by a questionnaire using the Snore Outcomes Survey (SOS) and the Epworth Sleepiness Scale (ESS). Postoperative pain, speech and swallowing disturbances were also evaluated. The postoperative scores of SOS and ESS all significantly improved (p<0.05). Postoperative pain, speech and swallowing disturbances were all mild 1-3 days after treatment. With the success of treatment defined as a postoperative snoring index (SI) of <3 or a reduction of the SI by >5 points by the visual analogue scale, the success rate was 81.3% in patients with a respiratory disturbance index (RDI) of <20, and 50% in those with an RDI of >20. We conclude that RVTR of the soft palate is an effective treatment for snoring, resulting in only mild postoperative discomfort. A patient whose RDI was <20 had a higher success rate with a single RVTR treatment.

Entities:  

Mesh:

Year:  2003        PMID: 14686565

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  2 in total

1.  Reconstructive procedures for disturbed functions within the upper airway: pharyngeal breathing/snoring.

Authors:  Thomas Verse
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

2.  Comparative effects of snoring sound between two minimally invasive surgeries in the treatment of snoring: a randomized controlled trial.

Authors:  Li-Ang Lee; Jen-Fang Yu; Yu-Lun Lo; Ning-Hung Chen; Tuan-Jen Fang; Chung-Guei Huang; Wen-Nuan Cheng; Hsueh-Yu Li
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.